Sponsors (11)
The bill strengthens law-enforcement access to provider data to combat drug distribution while trading off significant user privacy protections and imposing compliance burdens on providers.
Law enforcement agencies and prosecutors gain routine, faster access to provider-held account records and a 90-day preservation duty so they can investigate and disrupt fentanyl, methamphetamine, counterfeit drugs, and illegal prescription distribution and secure evidence for prosecutions.
Providers and their employees receive statutory good-faith immunity when they preserve and disclose records under the law, reducing legal risk and encouraging cooperation with investigations.
The Department of Justice must report annually to Congress about provider reports and outcomes, increasing transparency about how many reports are made, how many are actionable, and resulting convictions.
Internet users (broad public) could lose content privacy because the law permits providers in some circumstances to disclose message content to DOJ, weakening existing content protections.
Large numbers of users' communications metadata and identifying information can be routinely collected from providers and handed to DOJ, reducing online privacy for many people even when content is not disclosed.
Gag provisions and limits on provider notice allow delays of up to 45 business days before users are informed their accounts were preserved or disclosed, reducing transparency for affected account holders.
Based on analysis of 3 sections of legislative text.
Requires online communication and remote computing providers to report, preserve, and disclose records to the Attorney General about accounts, content, or transactions allegedly linked to fentanyl, other Schedule I/II drugs, or listed chemical precursors.
Requires online communication platforms and remote computing service providers to report, preserve, and disclose records to the Attorney General about accounts, content, or transactions that are alleged to have been used to facilitate distribution of Schedule I or II controlled substances, fentanyl-related substances, or listed chemical precursors. The DOJ is given authority to set regulations and guidelines, and providers that act in good faith are given civil and criminal liability protections. Also creates definitions and procedures for reporting, preservation, disclosure, exemptions, and limitations, names the Attorney General as the recipient and enforcer, and includes a severability rule so surviving provisions remain if any part is held unconstitutional.
Introduced July 17, 2025 by Mariannette Miller-Meeks · Last progress July 17, 2025